References:
1-W. H. Geerts, D. Bergqvist, G. F. Pineo et al., “Prevention of venous
thromboembolism: American College of Chest Physicians evidence-based
clinical practice guidelines (8th edition),” Chest,
vol. 133, no. 6, pp. 381S–453S, 2008.
2-Warkentin TE. Drug-induced immune-mediated thrombocytopenia from
purpura to thrombosis. N Engl J Med 2007; 356: 891–3.
3-Gruel Y, Pouplard C, Nguyen P, Borg JY, Derlon A, Juhan-Vague I,
Regnault V, Samama M; FrenchHeparin-Induced Thrombocytopenia Study
Group. Biological and clinical features of low-molecular-weight
heparin-induced thrombocytopenia. Br J Haematol 2003; 121: 786–92.
4- John W Eikelboom, Stuart J Connolly, Martina Brueckmann, Christopher
B Granger, Arie P Kappetein, Michael J Mack, Jon Blatchford. Dabigatran
versus warfarin in patients with mechanical heart valves. N Engl J Med.
2013 Sep 26;369(13):1206-14. doi:10.1056/NEJMoa1300615. Epub 2013 Aug
31.
5- Helio P Guimarães, Pedro G M de Barros E Silva, Idelzuita L Liporace,
Roney O Sampaio, Flávio Tarasoutchi, Milena Paixão, Conrado R
Hoffmann-Filho et al. A randomized clinical trial to evaluate the
efficacy and safety of rivaroxaban in patients with bioprosthetic mitral
valve and atrial fibrillation or flutter: Rationale and design of the
RIVER trial Am Heart J. 2021 Jan; 231:128-136. doi:
10.1016/j.ahj.2020.10.001. Epub 2020 Oct 10.
6-Janion-Sadowska A, Papuga-Szela E,Łukaszuk R, Chrapek M, Undas A.
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial
Fibrillation and Thrombocytopenia. J Cardiovasc Pharmacol.
2018;72(3):153.
7- Helmut Baumgartner, Volkmar Falk, Jeroen J Bax, Michele De Bonis,
Christian Hamm, Per Johan Holm, Bernard Iung et al. 2017 ESC/EACTS
Guidelines for the management of valvular heart disease. European Heart
Journal, Volume 38, Issue 36, 21 September 2017, Pages 2739–2791,
https://doi.org/10.1093/eurheartj/ehx391
8- Tufano A, Guida A, Di Minno MN, et al. Prevention of venous
thromboembolism in medical patients with thrombocytopenia or with
platelet dysfunction: A review of the literature. Semin Thromb Hemost
2011; 37:267.
9- Samuelson Bannow BT, Lee A, Khorana AA, et al. Management of
cancer-associated thrombosis in patients with thrombocytopenia: guidance
from the SSC of the ISTH. J Thromb Haemost 2018; 16:1246.